UNSPSC 51263153: Bisoprolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H31NO4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2EX58570NP. Most nations, for tariff and trade purposes, schedule bisoprolol hydrochloride under HS 29221980. As of Q4 2014, BISOPROLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)NCC(COC1CCC(CC1)COCCOC(C)C)O.CL.

UNSPSC 51263153 Bisoprolol hydrochloride is a Commodity code that nominally designates a specific pharmaceutical product—a beta-blocker used in cardiovascular treatment. However, the recent state and local procurement activity tagged to this code does not align with its stated scope. Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, neither of which are bisoprolol or related cardiovascular pharmaceuticals. The mismatch suggests either a tagging error in the source system or that this code may be used as a placeholder or catch-all within certain jurisdictions' procurement processes. The code shows minimal clear activity directly supporting its nominal pharmaceutical scope in recent state and local solicitations.

The single recent opportunity on record—Seminole County's naloxone and drug deactivation systems IFB (IFB60459723LAS, due July 26, 2023)—does not represent genuine market activity under the bisoprolol code. Absent additional sourced evidence of state and local governments actually procuring bisoprolol hydrochloride, the code cannot be reliably characterized by issuing-body mix, geographic concentration, or representative work. Vendors should verify code assignment before pursuing opportunities tagged to this commodity unless the customer's procurement team explicitly confirms that the code correctly reflects the requirement.